Propranolol vs Corticosteroids for Infantile Hemangiomas
Authors:
- Carol LattoufCLCarol Lattouf
- Bertha BaumBBBertha Baum
- Michael McLeodMMMichael McLeod
- Lawrence A. SchachnerLSLawrence A. Schachner
- Ana M. DuarteADAna M. Duarte
- Elizabeth Alvarez ConnellyECElizabeth Alvarez Connelly
Open Access
- 1 December 2011
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 147 (12) , 1371-1376
Abstract
Research from JAMA Dermatology — Propranolol vs Corticosteroids for Infantile Hemangiomas — A Multicenter Retrospective AnalysisKeywords
This publication has 11 references indexed in Scilit:
- Efficacy of Propranolol in Hepatic Infantile Hemangiomas with Diffuse Neonatal HemangiomatosisThe Journal of Pediatrics, 2010
- Hypoglycemia in Children Taking Propranolol for the Treatment of Infantile HemangiomaArchives of Dermatology, 2010
- Propranolol for infantile haemangiomas: insights into the molecular mechanisms of actionBritish Journal of Dermatology, 2010
- Severe Hypoglycemia During Successful Treatment of Diffuse Hemangiomatosis with PropranololPediatric Dermatology, 2010
- Life‐threatening infantile haemangioma: a dramatic response to propranololJournal of the European Academy of Dermatology and Venereology, 2009
- Propranolol Treatment for Hemangioma of Infancy: Risks and RecommendationsPediatric Dermatology, 2009
- Propranolol for Severe Hemangiomas of InfancyNew England Journal of Medicine, 2008
- Prospective Study of Infantile Hemangiomas: Demographic, Prenatal, and Perinatal CharacteristicsThe Journal of Pediatrics, 2007
- The Nonrandom Distribution of Facial HemangiomasArchives of Dermatology, 2003
- Which Hemangiomas to Treat—and How?Archives of Dermatology, 1997